BIRMINGHAM, Ala., Jan. 7, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), the nation's largest owner and operator of inpatient rehabilitation hospitals, has been recognized by Forbes on their inaugural list of the Most Trusted Companies in America.
In partnership with research companies HundredX, Signal AI and Glassdoor, Forbes evaluated more than 2,000 large U.S.-based public companies across four key categories: customer trust, employee trust, investor trust and media sentiment, assessing hundreds of millions of data points. Of those 2,000 companies, only the top 300 made the Most Trusted Companies in America list. Encompass Health ranked fourth among companies included in the Health Care Equipment and Services category.
"Encompass Health prides itself on being the trusted choice in inpatient rehabilitation, so we are pleased to be recognized for our commitment to building and upholding trust with our patients, partners and investors," said Mark Tarr, president and chief executive officer of Encompass Health. "Our priority is providing compassionate, high-quality and individualized care to achieve the best outcomes for our patients. We look forward to continuing to expand our presence across the country to meet the demand for our services and make a meaningful difference in the communities we serve."
About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 166 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Becker's Hospital Review's 150 Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Encompass Health Media Contact:
Polly Manuel | 205-970-5912
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$102.91 |
Daily Change: | -0.09 -0.09 |
Daily Volume: | 299,309 |
Market Cap: | US$10.370B |
December 18, 2024 November 04, 2024 October 28, 2024 August 05, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load